Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for prevention of deep vein thrombosis after PICC catheterization
ChiCTR1900025948Phase 4Recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in deep vein thrombosis (DVT) (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Thrombosis occurrence. Started Sep 2019; status: recruiting.
02
Drugs
aspirin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR1900025948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025948.